SCHEMBL21281401

SCHEMBL21281401

BC12BC3(B)C(B)(B)C(=O)NC(=O)C3(B)N1C(=O)c1cc(F)cc(N)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19310041 0.81 — —
SCHEMBL21925221 0.71 — —
SCHEMBL21927072 0.69 AKR1B1 (0.32) —
SCHEMBL21281363 0.67 — —
SCHEMBL22199340 0.67 — —
SCHEMBL21281328 0.64 CYP19A1 (0.35) —
SCHEMBL23470212 0.64 — —
SCHEMBL19309922 0.63 AKR1B1 (0.33) —
SCHEMBL22199360 0.59 AKR1B1 (0.34) —
SCHEMBL23470170 0.59 DDB1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3527210-A1 COMPOSITION, APPLICATION THEREOF AND TREATMENT METHOD Kangpu Biopharmaceuticals, Ltd. (CN) 2019-08-21 — — EP disclosed
Send feedback